Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01842568




Registration number
NCT01842568
Ethics application status
Date submitted
17/04/2013
Date registered
29/04/2013
Date last updated
13/03/2023

Titles & IDs
Public title
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Scientific title
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Secondary ID [1] 0 0
VISION Cardiac Surgery
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Vascular Death 0 0
Myocardial Infarction 0 0
Stroke 0 0
Cardiac Surgery 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
All-cause mortality at 30-days after surgery
Timepoint [1] 0 0
30 days after surgery
Primary outcome [2] 0 0
Myocardial injuries that were not identified clinically during the first 5 days after surgery
Timepoint [2] 0 0
5 days after surgery
Primary outcome [3] 0 0
Composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device
Timepoint [3] 0 0
30 days after surgery
Primary outcome [4] 0 0
Composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device
Timepoint [4] 0 0
1 year after surgery
Secondary outcome [1] 0 0
Composite of vascular death, nonfatal myocardial infarction, nonfatal stroke, and mechanical assist device
Timepoint [1] 0 0
30 days after surgery
Secondary outcome [2] 0 0
Total mortality
Timepoint [2] 0 0
30 days after surgery
Secondary outcome [3] 0 0
Total mortality
Timepoint [3] 0 0
1 year after surgery
Secondary outcome [4] 0 0
Vascular mortality
Timepoint [4] 0 0
30 days after surgery
Secondary outcome [5] 0 0
Vascular mortality
Timepoint [5] 0 0
1 year after surgery
Secondary outcome [6] 0 0
Myocardial infarction
Timepoint [6] 0 0
30 days after surgery
Secondary outcome [7] 0 0
Myocardial infarction
Timepoint [7] 0 0
1 year after surgery
Secondary outcome [8] 0 0
Non-fatal cardiac arrest
Timepoint [8] 0 0
30 days after surgery
Secondary outcome [9] 0 0
Non-fatal cardiac arrest
Timepoint [9] 0 0
1 year after surgery
Secondary outcome [10] 0 0
Stroke
Timepoint [10] 0 0
30 days after surgery
Secondary outcome [11] 0 0
Stroke
Timepoint [11] 0 0
1 year after surgery
Secondary outcome [12] 0 0
Implantation of mechanical assist device
Timepoint [12] 0 0
30 days after surgery
Secondary outcome [13] 0 0
Implantation of mechanical assist device
Timepoint [13] 0 0
1 year after surgery
Secondary outcome [14] 0 0
Cardiac transplant
Timepoint [14] 0 0
30 days after surgery
Secondary outcome [15] 0 0
Cardiac transplant
Timepoint [15] 0 0
1 year after surgery
Secondary outcome [16] 0 0
Repeat cardiac revascularization procedures
Timepoint [16] 0 0
30 days after surgery
Secondary outcome [17] 0 0
Repeat cardiac revascularization procedures
Timepoint [17] 0 0
1 year after surgery
Secondary outcome [18] 0 0
Congestive heart failure
Timepoint [18] 0 0
30 days after surgery
Secondary outcome [19] 0 0
Congestive heart failure
Timepoint [19] 0 0
1 year after surgery
Secondary outcome [20] 0 0
New atrial fibrillation
Timepoint [20] 0 0
30 days after surgery
Secondary outcome [21] 0 0
New atrial fibrillation
Timepoint [21] 0 0
1 year after surgery
Secondary outcome [22] 0 0
Pulmonary embolus
Timepoint [22] 0 0
30 days after surgery
Secondary outcome [23] 0 0
Pulmonary embolus
Timepoint [23] 0 0
1 year after surgery
Secondary outcome [24] 0 0
Deep venous thrombosis
Timepoint [24] 0 0
30 days after surgery
Secondary outcome [25] 0 0
Deep venous thrombosis
Timepoint [25] 0 0
1 year after surgery
Secondary outcome [26] 0 0
Major bleeding
Timepoint [26] 0 0
30 days after surgery
Secondary outcome [27] 0 0
Major bleeding
Timepoint [27] 0 0
1 year after surgery
Secondary outcome [28] 0 0
New dialysis
Timepoint [28] 0 0
30 days after surgery
Secondary outcome [29] 0 0
New dialysis
Timepoint [29] 0 0
1 year after surgery
Secondary outcome [30] 0 0
Infection
Timepoint [30] 0 0
30 days after surgery
Secondary outcome [31] 0 0
Infection
Timepoint [31] 0 0
1 year after surgery
Secondary outcome [32] 0 0
Re-hospitalization for a vascular reason
Timepoint [32] 0 0
30 days after surgery
Secondary outcome [33] 0 0
Re-hospitalization for a vascular reason
Timepoint [33] 0 0
1 year after surgery
Secondary outcome [34] 0 0
Chronic incisional pain
Timepoint [34] 0 0
30 days after surgery
Secondary outcome [35] 0 0
Chronic incisional pain
Timepoint [35] 0 0
1 year after surgery
Secondary outcome [36] 0 0
Frailty
Timepoint [36] 0 0
30 days after surgery
Secondary outcome [37] 0 0
Frailty
Timepoint [37] 0 0
1 year after surgery

Eligibility
Key inclusion criteria
1. Age = 18 years.

2. Patients who have undergone cardiac surgery. This includes coronary artery bypass
grafting and all open heart procedures such as valvular repairs/replacement.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Previously enrolled in the VISION Cardiac Surgery Study.

2. Patients who have undergone an isolated pericardial window, pericardiectomy, permanent
pacemaker or defibrillator implantation.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/2013
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/12/2023
Actual
Sample size
Target
Accrual to date
Final
15989
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Royal Prince Alfred Hospital - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
Brazil
State/province [2] 0 0
Rio Grande Do Sul
Country [3] 0 0
Brazil
State/province [3] 0 0
RS
Country [4] 0 0
Brazil
State/province [4] 0 0
São Paulo
Country [5] 0 0
Canada
State/province [5] 0 0
Ontario
Country [6] 0 0
China
State/province [6] 0 0
XinJiang
Country [7] 0 0
Hong Kong
State/province [7] 0 0
Hong Kong, SAR
Country [8] 0 0
Italy
State/province [8] 0 0
Bari
Country [9] 0 0
Italy
State/province [9] 0 0
Milan
Country [10] 0 0
Malaysia
State/province [10] 0 0
Kuala Lumpur
Country [11] 0 0
Poland
State/province [11] 0 0
Gdansk
Country [12] 0 0
Russian Federation
State/province [12] 0 0
Kemerovo
Country [13] 0 0
Russian Federation
State/province [13] 0 0
Novosibirsk
Country [14] 0 0
Spain
State/province [14] 0 0
Barcelona
Country [15] 0 0
United Kingdom
State/province [15] 0 0
Essex
Country [16] 0 0
United Kingdom
State/province [16] 0 0
Lancashire
Country [17] 0 0
United Kingdom
State/province [17] 0 0
Merseyside
Country [18] 0 0
United Kingdom
State/province [18] 0 0
Edinburgh
Country [19] 0 0
United Kingdom
State/province [19] 0 0
Wolverhampton

Funding & Sponsors
Primary sponsor type
Other
Name
Population Health Research Institute
Address
Country
Other collaborator category [1] 0 0
Commercial sector/Industry
Name [1] 0 0
Abbott Diagnostics Division
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Worldwide over 2 million adults (>30,000 Canadians) undergo heart surgery annually. Although
heart surgery provides important survival benefits, it is associated with potential major
complications such as death, stroke, and heart attack. There is promising evidence that
measurement of heart injury markers after surgery will identify patients at risk of death or
major complications.

This study will determine the current incidence of major complications in a representative
sample of 15,000 contemporary adult patients undergoing heart surgery. Knowing the current
burden of complications will inform clinicians, administrators, government and granting
agencies about resources required to address the problem. This study will also establish the
role of measuring heart injury markers to identify important heart injury after heart surgery
and the proportion that would go undetected without routine heart injury marker monitoring.
This information will facilitate further studies of timely interventions. In summary, the
VISION Cardiac Surgery Study addresses fundamental questions that will have profound public
health implications given the millions of adults worldwide who undergo heart surgery
annually.
Trial website
https://clinicaltrials.gov/ct2/show/NCT01842568
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
P.J. Devereaux, MD, PhD
Address 0 0
McMaster University
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT01842568